GRANT, Kathleen A., PIENAAR, Fredrieka M., BRUNDYN, Karen, SWART, Gillaume, GERICKE, George S., MYBURGH, Ettienne J., WRIGHT, Colleen A., APFFELSTAEDT, Justus P. und KOTZE, Maritha J., 2015. Incorporating microarray assessment of HER2 status in clinical practice supports individualised therapy in early-stage breast cancer. Breast. 1 April 2015. Vol. 24, no. 2, p. 137-142. DOI 10.1016/j.breast.2014.12.006.
Elsevier - Harvard (with titles)Grant, K.A., Pienaar, F.M., Brundyn, K., Swart, G., Gericke, G.S., Myburgh, E.J., Wright, C.A., Apffelstaedt, J.P., Kotze, M.J., 2015. Incorporating microarray assessment of HER2 status in clinical practice supports individualised therapy in early-stage breast cancer. Breast 24, 137-142. https://doi.org/10.1016/j.breast.2014.12.006
American Psychological Association 7th editionGrant, K. A., Pienaar, F. M., Brundyn, K., Swart, G., Gericke, G. S., Myburgh, E. J., Wright, C. A., Apffelstaedt, J. P., & Kotze, M. J. (2015). Incorporating microarray assessment of HER2 status in clinical practice supports individualised therapy in early-stage breast cancer. Breast, 24(2), 137-142. https://doi.org/10.1016/j.breast.2014.12.006
Springer - Basic (author-date)Grant KA, Pienaar FM, Brundyn K, Swart G, Gericke GS, Myburgh EJ, Wright CA, Apffelstaedt JP, Kotze MJ (2015) Incorporating microarray assessment of HER2 status in clinical practice supports individualised therapy in early-stage breast cancer.. Breast 24:137-142. https://doi.org/10.1016/j.breast.2014.12.006
Juristische Zitierweise (Stüber) (Deutsch)Grant, Kathleen A./ Pienaar, Fredrieka M./ Brundyn, Karen/ Swart, Gillaume/ Gericke, George S./ Myburgh, Ettienne J./ Wright, Colleen A./ Apffelstaedt, Justus P./ Kotze, Maritha J., Incorporating microarray assessment of HER2 status in clinical practice supports individualised therapy in early-stage breast cancer., Breast 2015, 137-142.